Pfizer Proven Miracle To Fight Against ROS1 Lung Cancer Through Xalkori

September 28, 2014 9:09 PM

5 0

Pfizer Proven Miracle To Fight Against ROS1 Lung Cancer Through Xalkori

In annual congress of European Society for Medical Oncology (ESMO) in Madrid the researchers presented the study describing Xalkori as a wonder drug. The drug Xalkori manufactured by Pfizer Incorporation is new in the market and is made to treat a rare type of lung cancer- the non small cell lung cancer (NSCLC). A clinical trial has shown surprising effects of Xalkori in reducing the size of this tumour and can be an effective treatment for people suffering from this uncommon form of illness related to gene defect.

The lead investigator Dr. Alice Shaw, from Boston’s Massachusetts General Hospital Cancer Center, reported that this clinical trial is the first solid study to establish crizotinib’s activity in victims of lung cancer who are tested positive for ROS1 and confirms that ROS1 is an authentic therapeuti...

Read more

To category page

Loading...